Skeletal Muscle Mass Loss During Cancer Treatment: Differences by Race and Cancer Site.
OBJECTIVES: To examine skeletal muscle mass change in a racially diverse sample of patients undergoing cancer treatment, determine significant predictors of muscle mass loss, and explore the interaction of race and cancer site. SAMPLE & SETTING: A retrospective analysis was conducted for 212 patient...
| Publicado en: | Oncology Nursing Forum Vol. 47; no. 5; pp. 557 - 567 |
|---|---|
| Autores principales: | , , , , , , |
| Formato: | research tables/charts Journal Article |
| Publicado: |
Oncology Nursing Society
Sep2020
|
| Acceso en línea: | Ver este registro en EBSCOhost |
| fields | @attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=145291905&site=ehost-live header: @attributes: shortDbName: ccm uiTerm: 145291905 longDbName: CINAHL Complete uiTag: AN controlInfo: bkinfo: dissinfo: jinfo: jid: 0190535X 4F0 jtl: Oncology Nursing Forum issn: 0190535X maglogo: N pubinfo: dt: Sep2020 vid: 47 iid: 5 pid: 12496 pub: Oncology Nursing Society place: Pittsburgh, Pennsylvania artinfo: ui: 145291905 145291905 145291905 10.1188/20.ONF.557-566 145291905 ppf: 557 ppct: 10 formats: fmt: @attributes: type: P tig: atl: Skeletal Muscle Mass Loss During Cancer Treatment: Differences by Race and Cancer Site. aug: au: Min Kyeong Jang Chang Gi Park Susan Hong Laddu, Deepika Hongjin Li Rhee, Esther Doorenbos, Ardith Z. affil: Postdoctoral fellow in the Cancer Center and in the College of Nursing, University of Illinois at Chicago sug: subj: Neoplasms Drug Therapy Chemotherapy, Cancer Adverse Effects Sarcopenia Chemically Induced Muscle, Skeletal Pathology Sarcopenia Risk Factors Risk Assessment Race Factors Neoplasms by Site Human Retrospective Design Record Review Cancer Patients Academic Medical Centers Tomography, X-Ray Computed Descriptive Statistics Rectal Neoplasms Complications Black Persons Male Female Adult Middle Age Aged Aged, 80 and Over Illinois Paired T-Tests Multiple Linear Regression Data Analysis Software Adult: 19-44 years Middle Aged: 45-64 years Aged: 65+ years Aged, 80 & over Male Female ab: OBJECTIVES: To examine skeletal muscle mass change in a racially diverse sample of patients undergoing cancer treatment, determine significant predictors of muscle mass loss, and explore the interaction of race and cancer site. SAMPLE & SETTING: A retrospective analysis was conducted for 212 patients seeking treatment at a university hospital clinic. METHODS & VARIABLES: Skeletal muscle mass index (SMI) was determined by computed tomography at the time of cancer diagnosis and with cancer treatment. RESULTS: One hundred thirty-four patients (63%) had SMI loss with cancer treatment. Race and cancer site were found to be significant predictors of SMI loss. Compared to other racial groups, non-Hispanic Black (NHB) patients had the greatest SMI loss (p < 0.001) with cancer treatment. NHB patients with rectal cancer experienced the greatest SMI loss compared to patients of other races and cancer types. IMPLICATIONS FOR NURSING: To improve survivorship care for patients with cancer, it is essential to develop strategies for assessing and managing skeletal muscle mass loss throughout treatment, particularly for NHB patients with rectal cancer. pubtype: Academic Journal doctype: research tables/charts Journal Article ougenre: Article language: English refInfo: holdings: @attributes: islocal: N |
|---|